Form: EFFECT

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: December 22, 2025
Accession Number: 0001193125-25-326996
Submission Type: POS AM
CIK: 0001075880
Company Name: KAZIA THERAPEUTICS LTD
File Number: 333-284606